Prescient Medical, Inc. Acquires New Technology to Detect Inflammation in Coronary Blo... ( Time Resolved Light Induced Fluore...)

Prescient Medical, Inc. Acquires New Technology to Detect Inflammation in Coronary Blood Vessels

Date:11/13/2007

Time Resolved Light Induced Fluorescence Spectroscopy (TR-LIFS) to be Combined with Other PMI Diagnostic Technologies to Help Prevent Deaths

Related to Heart Attacks

DOYLESTOWN, Pa., Nov. 13 /PRNewswire/ -- Prescient Medical, Inc., a privately held medical device company dedicated to reducing deaths from heart attacks, announces the acquisition of a new technology that identifies and quantifies metabolic activity and inflammation in human artery tissue by measuring the time it takes for light to dissipate after the tissue has been excited with ultra-short light pulses.

The new technique, called Time Resolved Light Induced Fluorescence Spectroscopy (TR-LIFS), exploits the phenomenon that bi-products of metabolic activity behave differently than surrounding tissue. In TR-LIFS, a short light pulse (picoseconds) is used to excite the tissue, and then the resulting light that emanates from the tissue is monitored over a brief time span (several nanoseconds). This technology has been verified by several research groups to accurately detect inflammation in human tissue in vitro and in vivo.

Arterial plaques are associated with an array of biochemical, functional, and structural changes that can be readily identified with optical techniques. Another Prescient Medical technology, Raman spectroscopy, has been proven to provide exquisite compositional detail, in vivo, of arterial wall constituents and will be entering clinical trials early next year. By combining TR-LIFS with Raman spectroscopy, Prescient's burgeoning arsenal of tools to assist physicians in assessing plaque vulnerability is buttressed with a formidable new diagnostic weapon.

"We believe the development of TR-LIFS technology into a diagnostic product will provide another valuable tool in the fight against heart disease," said Patricia Scheller, Prescient's chief executive officer. "Since 80 percent of all heart attacks are caused by soft plaques tha
'/>"/>

SOURCE Prescient Medical, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
2. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
3. U.S. Preventive Medicine Acquires Specialty Disease Management
4. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
5. Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble
6. Novel Technology Breaks Through Cancer Pain
7. CLIA Waiver Submitted for Rapid HIV Test Employs StatSures Barrel Technology
8. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
9. Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics BioZ(R) ICG Technology
10. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
11. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results

Post Your Comments:

(Date:12/1/2009)... Germany, Dec. 1 Matrox Graphics I...ics solutions, is pleased to announce that FUJIFIL...) Series display controller boards in several of ...ilm Synapse. ,, Fujifilm is one of the leading... the world,s first internet-based PACS (SYNAPSE) a...

(Date:12/1/2009)...ewswire/ -- Reproductive Partners Medical Group, I...r (eSET) Encouragement Program to provide a financ...y and a good prognosis for success to consider red... embryo. ,, The biggest issue in advanced repro... multiple pregnancies, even twin pregnancies. In t...

(Date:12/1/2009)...ire/ -- Johnson & Johnson Pharmaceutical Resea... it has submitted a New Drug Application (NDA) to ...pentadol extended release (ER) tablets, an investi...rate to severe chronic pain in patients 18 years o...in that persists for long periods of time - usuall...

[0] FUJIFILM Europe Teams Synapse with Matrox Xenia [0] Reproductive Partners Announces Elective Single Embryo Transfer (eSET) Encouragement Program [0] New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain

...rmaceuticals, Inc. (Nasdaq: RIGL ) today announce..., has begun a Phase 1 clinical trial of an,inhaled...inhibitor, R343,for the treatment of allergic asth... clinical portfolio., Under the terms of the comp...ceive a $5 million milestone payment from Pfizer f...

...sdaq: RDYN ) announced today that President and C...ticipate on the New and Powerful Anti-infectives,p...nference. The panel,discussion will take place at ...Westin Times Square in New York City., A live aud...le on the,investor relations section of the compan...

Other Medicine Technology:Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer 2 Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer 3

Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer Replidyne to Participate on Anti-infective Panel at RBC Capital Markets Healthcare Conference

(Date:12/1/2009)...Newswire/ -- Reportlinker.com announces that a new...gue: ,, The Future of Monoclonal Antibodies - ..., Product Pipeline and Deals Analysis ,, http...oclonal-Antibodies---Market-Forecasts-to-2015-Comp...alysis.html ,, Summary ,, The author has...

(Date:12/1/2009)...re-USNewswire/ -- The Kerlan Jobe Orthopaedic Clin...greed to pay the United States $3 million to settl...rom HealthSouth Corporation, the Justice Departmen...ves allegations that HealthSouth paid kickbacks to...onations to the Kerlan Jobe Foundation, loan forgi...

(Date:12/1/2009)...ewswire-USNewswire/ -- A scientist who broadened t...ways we can control and relieve it -- has won the ... Psychology. ,, Ronald Melzack, psychology prof...as selected for the award from among 24 nomination...ry but instead in their brain through a pathway th...

(Date:12/1/2009)...hs more likely, British study finds , , ... who are poor are more likely to deliver a very pr...oth groups typically receive equal care, a new Bri... research team said their findings show the need t...c status and preterm birth. , For the study, th...

(Date:12/1/2009)...iteria based on computed tomography (CT) imaging o...es after chemotherapy with the drug bevacizumab ma...according to a study in the December 2 issue of J...c (toxic to cells) chemotherapy is associated with...ectal cancer and higher pathologic response rates ...

[1] Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis [0] Los Angeles' Kerlan Jobe Orthopaedic Clinic Pays $3 Million to Settle Kickback Allegations [0] Scientist Who Helps Explain Pain Wins Grawemeyer Award [0] More Preemies Born Among the Poor [0] Criteria based on CT imaging after chemotherapy may help predict survival

...AN, Va., April 6 Improper food preparation habits...bits are not just found in food processing plants ...One third of the participants in a Dutch study of ...e used with the raw chicken, not washing their han...

...ta-based company allows patients to hold their pla...nt care centers , , ATLANTA, April 6 InQuickER,...p, Inc., one of the Southeast,s most reputable pub...as it pursues national recognition as a first move...

...TOWN, South Africa, April 6 Expanding therapeutic...growth within the Kenyan pharmaceutical industry. ... for the largest burden of disease in Kenya, non-c...(Logo: http://www.newscom.com/cgi-bin/prnh/20081...

... In an effort to educate Americ...tress and to bring awareness to proactive strategi... Awareness month. Internet retailer Magazines.com ...009 -- Knowing the difference between good stress ...

... Premier Plastic Surgery, Pitt...urgery Center welcome Ana C. Busquets, MD, FAAD, B... Upper St. Clair, PA (Vocus) April 5, 2009 ...urgery medical spas offering a wide range of medic...

...ple customer agreements for Soarian Clinicals and ... a banner year for the system that streamlines the...patient-safety initiatives. , , CHICAGO, April 5 ...for its enterprise-wide clinical workflow system...

Other Medicine News:Health News:Good Kitchen Practices Can Keep You and Your Children From Getting Sick 2 Health News:Imagine No More Waits for Emergency Room Care ... InQuickER Chooses Trevelino/Keller Communications to Launch First Service of Its Kind 2 Health News:Kenyan Pharmaceutical Industry Can Expect Significant Growth Despite Global Conditions, Finds Frost & Sullivan 2 Health News:Kenyan Pharmaceutical Industry Can Expect Significant Growth Despite Global Conditions, Finds Frost & Sullivan 3 Health News:Cope with Recession-Related Stress with a Lifestyle Magazine Subscription 2 Health News:Pittsburgh Day Spa Welcomes Dermatologist, Ana C. Busquets, MD, FAAD And Is Accepting New Patients In Upper St. Clair And Cranberry Locations 2 Health News:Pittsburgh Day Spa Welcomes Dermatologist, Ana C. Busquets, MD, FAAD And Is Accepting New Patients In Upper St. Clair And Cranberry Locations 3 Health News:Pittsburgh Day Spa Welcomes Dermatologist, Ana C. Busquets, MD, FAAD And Is Accepting New Patients In Upper St. Clair And Cranberry Locations 4 Health News:Siemens Announces Latest Contracts, Recent 'Go Lives,' and Strong Customer Support for its Workflow-Enhancing Healthcare IT Solution Soarian Clinicals, at HIMSS 2009 2 Health News:Siemens Announces Latest Contracts, Recent 'Go Lives,' and Strong Customer Support for its Workflow-Enhancing Healthcare IT Solution Soarian Clinicals, at HIMSS 2009 3 Health News:Siemens Announces Latest Contracts, Recent 'Go Lives,' and Strong Customer Support for its Workflow-Enhancing Healthcare IT Solution Soarian Clinicals, at HIMSS 2009 4

Good Kitchen Practices Can Keep You and Your Children From Getting Sick Imagine No More Waits for Emergency Room Care ... InQuickER Chooses Trevelino/Keller Communications to Launch First Service of Its Kind Kenyan Pharmaceutical Industry Can Expect Significant Growth Despite Global Conditions, Finds Frost & Sullivan Cope with Recession-Related Stress with a Lifestyle Magazine Subscription Pittsburgh Day Spa Welcomes Dermatologist, Ana C. Busquets, MD, FAAD And Is Accepting New Patients In Upper St. Clair And Cranberry Locations Siemens Announces Latest Contracts, Recent 'Go Lives,' and Strong Customer Support for its Workflow-Enhancing Healthcare IT Solution Soarian Clinicals, at HIMSS 2009

C-FLAT Lateral Flow Assay Platform

Iso-Electric Determination Kit

Coat-Block-Run Conjugation Kit pH 5-8

Goat Anti-Rabbit IgG (H & L) Antibody, Gold Conjugated, 50 OD

Medicine Products:

C-FLAT Lateral Flow Assay Platform Iso-Electric Determination Kit Coat-Block-Run Conjugation Kit pH 5-8 Goat Anti-Rabbit IgG (H & L) Antibody, Gold Conjugated, 50 OD

Prescient Medical, Inc. Acquires New Technology to Detect Inflammation in Coronary Blo...( Time Resolved Light Induced Fluore...),Health